Sysmex (0YX) Stock Overview
Engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
0YX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sysmex Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥8.00 |
| 52 Week High | JP¥18.20 |
| 52 Week Low | JP¥6.60 |
| Beta | 0.66 |
| 1 Month Change | 4.58% |
| 3 Month Change | 4.58% |
| 1 Year Change | -52.10% |
| 3 Year Change | -58.62% |
| 5 Year Change | -72.09% |
| Change since IPO | -28.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0YX | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 10.3% | -5.1% | -2.4% |
| 1Y | -52.1% | -26.5% | -0.2% |
Return vs Industry: 0YX underperformed the German Medical Equipment industry which returned -23.9% over the past year.
Return vs Market: 0YX underperformed the German Market which returned 2.1% over the past year.
Price Volatility
| 0YX volatility | |
|---|---|
| 0YX Average Weekly Movement | 12.1% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in DE Market | 14.4% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: 0YX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 0YX's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 10,533 | Hisashi Ietsugu | www.sysmex.co.jp |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd.
Sysmex Corporation Fundamentals Summary
| 0YX fundamental statistics | |
|---|---|
| Market cap | €4.92b |
| Earnings (TTM) | €243.21m |
| Revenue (TTM) | €2.73b |
Is 0YX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0YX income statement (TTM) | |
|---|---|
| Revenue | JP¥502.95b |
| Cost of Revenue | JP¥242.15b |
| Gross Profit | JP¥260.80b |
| Other Expenses | JP¥216.05b |
| Earnings | JP¥44.75b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 71.81 |
| Gross Margin | 51.85% |
| Net Profit Margin | 8.90% |
| Debt/Equity Ratio | 6.4% |
How did 0YX perform over the long term?
See historical performance and comparisonDividends
Does 0YX pay a reliable dividends?
See 0YX dividend history and benchmarks| Sysmex dividend dates | |
|---|---|
| Ex Dividend Date | Mar 30 2026 |
| Dividend Pay Date | Jun 30 2026 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 109 days |
Does 0YX pay a reliable dividends?
See 0YX dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/11 11:47 |
| End of Day Share Price | 2026/03/11 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sysmex Corporation is covered by 29 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Masahiro Nakanomyo | Barclays |
| Kei Takeuchi | BofA Global Research |
| Ritsuo Watanabe | BofA Global Research |